Advertisement

Topics

Latest "Global Propionaldehyde 123386 Market Research Report Forecast 2017" News Stories

12:00 EDT 25th March 2019 | BioPortfolio

Here are the most relevant search results for "Global Propionaldehyde 123386 Market Research Report Forecast 2017" found in our extensive news archives from over 250 global news sources.

More Information about Global Propionaldehyde 123386 Market Research Report Forecast 2017 on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Global Propionaldehyde 123386 Market Research Report Forecast 2017 for you to read. Along with our medical data and news we also list Global Propionaldehyde 123386 Market Research Report Forecast 2017 Clinical Trials, which are updated daily. BioPortfolio also has a large database of Global Propionaldehyde 123386 Market Research Report Forecast 2017 Companies for you to search.

Showing "Global Propionaldehyde 123386 Market Research Report Forecast 2017" News Articles 1–25 of 52,000+

Monday 25th March 2019

Daon Among First to Receive FIDO2 Certification

Global biometric identity assurance leader and FIDO Alliance Board member receives UAF 1.1 certifications concurrently Daon, a global leader in biometric identity technology, today announced certification by the FIDO Alliance for the FIDO2 protocol on server, as well as for the UAF 1.1 protocol on server and Android client SDK. FIDO2, w...


CStone appoints three distinguished oncology leaders Drs. Paul A. Bunn, Jr., Elizabeth M. Jaffee and Richard S. Finn to its Scientific Advisory Board

SHANGHAI, March 25, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone"; HKEX: 2616) is pleased to announce the appointment of three internationally renowned oncologists Paul A. Bunn, Jr., MD, Elizabeth M. Jaffee, MD, and Richard S. Finn, MD, as the company's Scientific Advisory Board (SAB) members. With their deep scientific and medical expertise as well as extensive leadership and ad...

The American Journal of Managed Care® Announces the Institute for Value-Based Medicine® VB-Onc™ Meeting Taking Place in Chicago

This meeting will focus on the future of the Oncology Care Model and other alternative payment models in oncology The American Journal of Managed Care® (AJMC®), the leading peer-reviewed journal dedicated to issues in managed care, with its Institute for Value-Based Medicine® will host a regional VB-Onc™ meeting that will provide an overview of th...


Biofrontera AG: Biofrontera, Inc., USA, acquires Cutanea Life Sciences, Inc., USA

Biofrontera AG / Key word(s): Mergers & Acquisitions Biofrontera AG: Biofrontera, Inc., USA, acquires Cutanea Life Sciences, Inc., USA 25-March-2019 / 15:00 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. Ad-hoc...

Sleep and Aging Share Connection with Oxidative Stress

After drinking a mysterious potion, Rip Van Winkle slept for 20 years and finally awoke an old man. Perhaps he would have avoided the potion had it been labeled “oxidative stress,” which refers to byproducts of mitochondrial activity that have been associated with lifespan, aging, and degenerative disease. Oxidative stress, scientists now report, influences sleep-control […] The post Sle...

All doctors working night shifts should have a room with a bed

The Health Education England report calling for on-call rooms and resting places to be reinstated is commendable.1In 2005 I was one of the pioneers of the concept of consultants sleeping in when...

R&D Market Pulse: U.S. Auto Continue E-Vehicle Plans

NewsAt its March meeting last Wednesday, the Federal Reserve indicated that they are unlikely to raised short-term interest rates in 2019.Staff A

Trianni mouse model tapped for HIV vaccine research

Trianni and San Diego Biomedical Research Institute enter license agreement for the use of the Trianni Mouse in HIV vaccine research.

To Advance Collaboration in Precision Medicine, Bio-IT World Opens Global Event to the Public April 16-18, 2019

Through April 5, Register for Complimentary Exhibit Hall & Keynote Pass to Boston Conference & Expo In the spirit of open collaboration, the world’s premier bio-IT conference is inviting the community to experience and contribute to the future of precision medicine—together. With a focus on AI, data science and other “data-driven...

Fathers’ Secondhand Smoke Puts Unborn Babies at Risk of Heart Defects

Fathers who smoke may be putting their unborn children at risk of congenital heart defects (CHDs), according to research reported by scientists at Xiangya School of Public Health, Central South University, in Changsha, China. The research, carried out as a meta-analysis of data from 125 studies involving more than 100,000 children with CHDs, showed that […] The post Fathers’ Secondhand...

Child poverty in Scotland set to worsen despite targets set in 2017

Child poverty in Scotland is projected to hit a 20 year high in the next few years, despite ambitious targets set by the Scottish government to reduce the problem.This warning comes from the...

Philips, Delta Dental of California partner to advance oral health and improve healthcare outcomes

The companies plan to lend their respective expertise and conduct research in a joint effort to build integrated insurance and oral hygiene and wellness solutions within an evolving The post Philips, Delta Dental of California partner to advance oral health and improve healthcare outcomes appeared first on Compelo Medical Devices - Latest industry news and analysis.

Kazia to present on Cantrixil at American Association for Cancer Research (AACR) 2019 Annual Meeting

SYDNEY, March 25, 2019 /PRNewswire/ -- Australian oncology-focused biotech company Kazia Therapeutics Ltd (ASX: KZA, NASDAQ: KZIA) has been selected to present data from the Phase I study of Cantrixil in ovarian cancer at the American Association for Cancer Research (AACR) 2019 Annual Meeting. AACR's Annual Meeting is one of the top-tier academic conferences worldwide and b...

Lantheus Announces Upcoming Retirement of Chief Medical Officer in September 2019 and Promotion of Senior Vice President, Technical Operations to Chief Operations Officer

Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), parent company of Lantheus Medical Imaging, Inc. (“LMI”), a global leader in the development, manufacture and commercialization of innovative diagnostic imaging agents and products, today announced that Cesare Orlandi, M.D., Chief Medical Officer, will retire from the Company on September 2, 2...

SEQENS North America Wins Big at 2019 Life Science Leader Magazine CMO Leadership Awards

Wins “Top Performer” in 12 categories SEQENS North America (formerly PCI Synthesis, Inc.), a pharmaceutical manufacturer of new chemical entities (NCEs), generic active pharmaceutical ingredients (APIs), and other specialty chemical products, announced that it has won six additional 2019 Life Science Leader CMO Leadership Awards that...

AmpliPhi Biosciences Reports Fourth Quarter and Full Year 2018 Financial Results and Business Highlights

Entered into a merger agreement with C3J Therapeutics that is expected to result in an NYSE American-listed company focused on development of precisely-targeted bacteriophage therapeutics $10.0 million of new capital will be invested in combined company to be re-named Armata Pharmaceuticals Preliminary Merger pr...

CSHL President elected as AACR Academy Fellow

Cold Spring Harbor Laboratory President and CEO Dr. Bruce Stillman has been elected as a Fellow of the American Association for Cancer Research (AACR) Academy. Dr. Stillman’s research examines the process of DNA replication, and how errors in this process are involved in various diseases, including cancer. The AACR Academy recognizes and honors distinguished scientists... The post CSHL President...

Ambry Genetics to Develop Custom Assays Targeted to Patients with Hereditary Ovarian Cancer

Investigating new testing options to identify patients for clinical trials. ALISO VIEJO, Calif. (PRWEB) March 25, 2019 Ambry Genetics, a Konica Minolta Company (Ambry), and leading provider of clinical and research genetic testing, today announced a new laboratory services agreement with Clovis Oncology Inc., a biopharmaceutical company which shares Ambry’s commitment to advancing precision med...

ImpediMed Announces PREVENT Trial Accepted for Publication and Presentation at the 2019 Annual Meeting of the American Society of Breast Surgeons

Largest prospective, multi-center, randomized trial undertaken in the prevention of breast cancer-related lymphedema ImpediMed Limited (ASX:IPD), a global provider of medical technology to non-invasively measure, monitor and manage tissue composition and fluid status using bioimpedance spectroscopy (BIS), today announces that the pre-specified, ...

State Highlights: Dozens Of States Examine Rules To Upgrade EMS Care Of Stroke Patients; Fla. Lawmakers Eye Stronger Regulations For Cosmetic Surgeries

Media outlets report on news from California, Florida, Michigan, New Hampshire, Maryland, Virginia, Connecticut, Wisconsin, Georgia and Washington.

Personal, Banking Data From Millions Of Survivors Of U.S. Environmental Disasters Accidentally Shared By FEMA

A spokesman for the agency said 1.8 million people had both their banking information and addresses revealed, and about 725,000 people had just their addresses shared. The victims included those from the California wildfires in 2017 and Hurricanes Harvey, Irma and Maria.

Patients Are Confessing Suicidal Thoughts To Apps Meant To Manage Health Problems Like Diabetes, Leaving Startups To Grapple With What To Do

“To be honest, when we started this, I didn’t think it was as big an issue as it obviously is,” said Daniel Nathrath, CEO of Ada Health. The phenomenon, though, is, in some respects, no surprise: There’s a large body of research showing that people are more willing to confess potentially taboo thoughts to a computer than to a fellow human a few feet away.

Alzheimer’s trial discontinued due to inefficiency

Two global Phase III trials of the Alzheimer's drug aducanumab have been discontinued, after the drug failed to hit efficacy targets.

Watchdog Group Claims 'Cat Cannibalism' at USDA Research Facility

ArticleCats used for research at a USDA lab were fed portions of dead animals obtained from "Asian meat markets," a sensational new report alleges.

Turning Point Therapeutics Appoints Jim Mazzola to Lead Corporate Communication and Investor Relations

Turning Point Therapeutics, Inc., a clinical-stage precision oncology company designing and developing novel drugs to address treatment resistance, announced today the appointment of Jim Mazzola to lead corporate communication and investor relations, reporting to Chief Executive Officer Athena Countouriotis, M.D. "Jim joins at a pivotal ...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks